HealthFinSMEsabout 2 hours ago
Specific Biologics Raises $35M Series A
1 min read
Specific Biologics, a Toronto-based gene-editing company, raised $35M in Series A funding led by Hatteras Venture Partners. The round includes investors like Lumira Ventures and the BDC Life Sciences Venture Fund. CEO Brent Stead will use the capital to expand operations and R&D efforts for serious genetic diseases.
Level
Hype check
Tap to vote and see what everyone thinks.